US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,310.81

-3.0045-0.23%

Number of Gainers:9

Number of Losers:11

Number of Flat:- -

PE:- -

High:1,317.52

Open:1,315.86

Low:1,308.89

Close:1,313.92

Loading ...

Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review

MT Newswires Live

EXCLUSIVE-Kennedy aide and vaccine critic questions recent expert recommendations

BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official

Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator -- Barrons.com

Moderna Falls 12%, Pfizer Falls 3.3% and Novavax Falls 6.3%

THOMSON REUTERS

BUZZ-Drugmakers fall as Trump signals announcement on medicine costs

Global Business Travel reports Q1 EPS 16c, consensus 17c

Moderna (MRNA) Gets a Hold from TD Cowen

BioNTech Se : Citigroup Cuts Target Price to $140 From $145

THOMSON REUTERS

BioNTech price target lowered to $140 from $145 at Citi

BioNTech SE Reports Q1 2025 Financial Results

Health Care Down on Mixed Earnings -- Health Care Roundup

Press Release: Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion

Optimism is Back for Biotech Stocks. This Time, It Could Last. -- Barrons.com

BioNTech price target lowered to $127 from $143 at BofA

Sector Update: Health Care Stocks Lower Monday Afternoon

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)

Narrower Guidelines for Covid-19 Booster Wouldn't Limit BioNTech's Customer Base Much -- Market Talk

European Equities Traded in the US as American Depositary Receipts Marginally Higher in Monday Trading

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1310.9148,"timestamp":1747230773835,"preClose":1313.9193,"halted":0,"volume":9141201,"delay":0,"changeRate":-0.002287,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-3.004517,"latestTime":"05-14 09:52:54 EDT","open":1315.863,"high":1317.5182,"low":1308.8901,"amount":400032995.553219,"amplitude":0.006567,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747252800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.567918,"peRate":21.178026,"turnoverRate":0.000587,"increases":9,"decrements":11,"flats":0,"marketCap":1080502726008,"floatMarketCap":1062198756530},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1317.5182,"amplitude":0.006567,"preClose":1313.9193,"low":1308.8901,"pbRate":"3.567918","latestPrice":1310.8065,"volume":9116603,"delay":0,"open":1315.863,"prevYearClose":1274.8187,"prevWeekClose":1327.5806,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1351.4436,"twentyDayClose":1326.1057,"sixtyDayClose":1391.6339,"secType":"PLATE","market":"US","turnoverRate":0.000587,"peRate":21.178026,"marketCap":1080564005240,"floatMarketCap":1062259839154,"timestamp":1747230768326,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":9,"down":11,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533664717","title":"Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2533664717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533664717?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:13","pubTimestamp":1746562414,"startTime":"0","endTime":"0","summary":"A recommendation to expand the indication for respiratory syncytial virus vaccines developed by Pfizer (PFE) and GSK (GSK) is being reviewed by a top aide to US Health Secretary Robert Kennedy, Reuter","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4533","LU0170899867.USD","SG9999001176.USD","LU0321505439.SGD","LU1883839398.USD","BK4585","BK4581","BK7095","GSK","LU0306806265.USD","SG9999001176.SGD","LU0985481810.HKD","BK4534","IE0002270589.USD","LU0321505868.SGD","BK4007","GSK.UK","BK4592","LU0306807586.USD","BK4532","LU0122379950.USD","LU0234572021.USD","LU0058720904.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","IE00BLSP4452.SGD","PFE.AU","SG9999002224.SGD","SG9999003800.SGD","LU1057294990.SGD","PFE","SG9999011175.SGD","SG9999002232.USD","LU0225284248.USD","LU1066053197.SGD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1066051498.USD","SGXZ57979304.SGD","BK4588","LU1894683264.USD","BK4568","BK4550","LU1829250122.USD","IE000M9KFDE8.USD","LU0456855351.SGD","LU1894683348.USD","LU0225771236.USD","BK4599","LU0868494617.USD"],"gpt_icon":1},{"id":"2533543669","title":"EXCLUSIVE-Kennedy aide and vaccine critic questions recent expert recommendations","url":"https://stock-news.laohu8.com/highlight/detail?id=2533543669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533543669?lang=en_us&edition=fundamental","pubTime":"2025-05-07 03:30","pubTimestamp":1746559824,"startTime":"0","endTime":"0","summary":"EXCLUSIVE-Kennedy aide and vaccine critic questions recent expert recommendationsKennedy aide Archer criticized vaccines on social media Archer seeks more data on RSV vaccine efficacyKennedy reviewing","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL6N3RE0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","IE00BBT3K403.USD","LU0575583348.USD","BK4581","SG9999013999.USD","LU0225771236.USD","IE0034235071.USD","LU1066053197.SGD","LU0109981661.USD","SG9999001176.USD","LU0321505868.SGD","LU1098665638.USD","LU1894683348.USD","BK4568","BK4599","LU0211331839.USD","BK4588","BK4533","LU1670756490.USD","BK5011","LU1645745479.HKD","LU1046248800.SGD","LU1023059063.AUD","IE00BQJZX424.USD","BK4592","LU1066051498.USD","LU1883839398.USD","IE00B19Z3581.USD","IE00BWDBJ516.SGD","LU0971552830.HKD","LU0545562505.USD","GSK.UK","LU1035777561.USD","LU1487256676.USD","LU0234572021.USD","LU1228905037.USD","BK4585","LU1400636491.USD","LU1202635105.USD","IE00BLSP4452.SGD","LU1057294990.SGD","PFE","SG9999003800.SGD","SG9999011175.SGD","LU1481600234.SGD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0122379950.USD","LU0985481810.HKD","LU0170899867.USD"],"gpt_icon":1},{"id":"2533631656","title":"BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official","url":"https://stock-news.laohu8.com/highlight/detail?id=2533631656","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533631656?lang=en_us&edition=fundamental","pubTime":"2025-05-07 02:20","pubTimestamp":1746555653,"startTime":"0","endTime":"0","summary":"BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official** Shares of vaccine maker Moderna MRNA.O and gene therapy developers fall between 12% and 22% after the U.S. FDA named Vinay Prasad as the director of its Center for Biologics Evaluation and Research ** Prasad was a fierce critic of COVID-19 vaccine and mask mandates** As the director of CBER, Prasad will oversee the regulation of vaccines and gene therapies** Shares of Moderna down 12.4%, Novavax NVAX.O down 5.2%, while Pfizer PFE.N, previously down after an announcement on medicine costs, extends losses to 3%** Shares of gene therapy developers such as Sarepta Therapeutics SRPT.O fall 21.5%, Taysha Gene Therapies TSHA.O fall 20.7%, Capricor Therapeutics CAPR.O down 20.3%** U.S.-listed shares of CRISPR Therapeutics CRSP.BN down 9.6%, Solid Biosciences SLDB.O down 15.3%, ** MRNA down 41.3% and SRPT down 61.1% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4N3RE1VN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","TSHA","BK4501","IE0002141913.USD","IE0002270589.USD","LU0122379950.USD","SG9999001176.SGD","BK4585","BK4568","IE00BJT1NW94.SGD","IE000M9KFDE8.USD","SG9999011175.SGD","LU1894683264.USD","SG9999013999.USD","LU0058720904.USD","LU0985481810.HKD","SLDB","SG9999003800.SGD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","BK4547","CAPR","NVAX","LU1066051498.USD","SGXZ57979304.SGD","SG9999002232.USD","LU0225771236.USD","BK4551","BK4139","LU0289739699.SGD","IE0009355771.USD","SG9999002224.SGD","SRPT","BK4548","LU1057294990.SGD","LU1066053197.SGD","BK4599","BK4533","IE00B2B36J28.USD","BK4581","BK4532","LU1883839398.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU1023059063.AUD","SG9999001176.USD","LU0306806265.USD","MRNA"],"gpt_icon":1},{"id":"2533663892","title":"Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2533663892","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533663892?lang=en_us&edition=fundamental","pubTime":"2025-05-07 02:04","pubTimestamp":1746554640,"startTime":"0","endTime":"0","summary":"Biotech and pharmaceutical stocks were sliding Tuesday afternoon as the Food and Drug Administration named Dr. Vinay Prasad, a critic of FDA policy and the U.S. Covid-19 response, as its top vaccine regulator.Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA's Center for Biologics Evaluation and Research in March, writing in his resignation letter that Robert F. Kennedy Jr., the secretary of Health and Human Services, \"wishes subservient confirmation of his misinformation and lies.\" Marks was perhaps the best-known career official within the agency.Novavax, another Covid-19 vaccine maker, was down 6.7%.Big pharma stocks with significant vaccine businesses were falling as well. American depositary receipt of GSK, which was roughly flat on the day as of 12:30 p.m., was down 1.7% by 1:30 p.m. Merck, another large vaccine maker, was down 4.6%, while Pfizer fell 3.3.%. This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published inde","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","BK4568","BK4007","BK4548","BK4533","BK4588","GSK.UK","BK4139","BK4501","BK4551","BK4585","MRNA","BK4534","GSK","NVAX","BK4532"],"gpt_icon":1},{"id":"2533668912","title":"Moderna Falls 12%, Pfizer Falls 3.3% and Novavax Falls 6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533668912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533668912?lang=en_us&edition=fundamental","pubTime":"2025-05-07 01:50","pubTimestamp":1746553819,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nFWN3RE2HJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","BK4547","LU0225771236.USD","NVAX","BK4501","BK4599","MRNA","PFE","BK4139","IE0002270589.USD","LU0868494617.USD","LU1066053197.SGD","BK4581","LU1894683264.USD","IE00B19Z3B42.SGD","BK4585","BK4588","IE00B19Z3581.USD","BK4533","BK4548","LU1057294990.SGD","LU1066051498.USD","LU0122379950.USD","SG9999001176.SGD","LU0234572021.USD","LU0985481810.HKD","LU0321505439.SGD","IE00BBT3K403.USD","LU0456855351.SGD","LU0225284248.USD","SG9999002224.SGD","SG9999003800.SGD","SG9999001176.USD","LU0170899867.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0058720904.USD","LU1883839398.USD","LU0289739699.SGD","BK4007","IE00BLSP4452.SGD","SG9999011175.SGD","LU1894683348.USD","LU0321505868.SGD","SG9999002232.USD","BK4568","BK4532","BK4550","BK4592","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2533656919","title":"BUZZ-Drugmakers fall as Trump signals announcement on medicine costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2533656919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533656919?lang=en_us&edition=fundamental","pubTime":"2025-05-06 23:21","pubTimestamp":1746544891,"startTime":"0","endTime":"0","summary":"BUZZ-Drugmakers fall as Trump signals announcement on medicine costs** Shares of U.S drugmakers fall after President Trump signaled he would make an announcement next week on the cost of medicines** Shares of Eli Lilly LLY.N and Abbvie ABBV.N fall 3% each, Merck MRK.N down 2.5%, Gilead GILD.O slip 2.4%, Amgen AMGN.O down 2.2%, Pfizer PFE.N fall 1.7%** The S&P 500 healthcare sector .SPXHC falls 1.5%** Trump said to reporters gathered at the White House the U.S. was being ripped off on medicine costs when compared to the rest of the world** He also said that he plans to announce pharmaceutical tariffs over the next two weeks** Trump's recent comments imply that pharma-specific tariff proposals are coming, but may not be as bad as expected, Jefferies says ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4N3RE1OX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDGV0183.EUR","LU1732800096.USD","AMGN","ABBV","LU2237443895.HKD","LU1814569148.SGD","LU2361044949.HKD","LU1623119135.USD","SG9999015978.USD","LU0985320562.USD","LU0029864427.USD","LU0889565916.HKD","LU1093756168.USD","IE00BLSP4452.SGD","BK4581","IE00B7SZLL34.SGD","LU2129689605.HKD","MRK","BK4559","LU0471298777.SGD","LU1496350502.SGD","LU0823416689.USD","LU2264538146.SGD","BK4568","LU0985481810.HKD","LLY","GILD","LU1941712264.USD","IE00B19Z3581.USD","LU0265550946.USD","BK4516","LU1035775433.USD","BK4532","LU1366192091.USD","LU1868837136.USD","LU1894683264.USD","PFE","LU0208291251.USD","LU0545039389.USD","SG9999014914.USD","LU1267930730.SGD","LU1934455194.USD","IE000M9KFDE8.USD","LU1983299246.USD","SGXZ81514606.USD","IE00B3PB1722.GBP","LU0354030511.USD","BK4592","SG9999011175.SGD","LU0097036916.USD"],"gpt_icon":1},{"id":"2533968729","title":"Global Business Travel reports Q1 EPS 16c, consensus 17c","url":"https://stock-news.laohu8.com/highlight/detail?id=2533968729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533968729?lang=en_us&edition=fundamental","pubTime":"2025-05-06 20:00","pubTimestamp":1746532859,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $621M, consensus $633.54M. Reports Q1 total transaction value $8.35B. Paul Abbott, Amex GBT’s Chief Executive Officer, stated: “...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/global-business-travel-reports-q1-eps-16c-consensus-17c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/global-business-travel-reports-q1-eps-16c-consensus-17c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","SG9999004303.SGD","BK4082","IE00BJJMRZ35.SGD","LU2133065610.SGD","BK4588","LU1691799644.USD","BK4533","BK4566","LU1721429741.USD","LU1023059063.AUD","LU1914381329.SGD","LU0266013472.USD","LU0868494617.USD","BK4592","SG9999002224.SGD","LU0170899867.USD","LU1057294990.SGD","IE00B2B36J28.USD","ABT","LU2237957811.SGD","BK4504","LU2112291526.USD","BK4585","IE0009355771.USD","LU1989763427.SGD","LU2089984988.USD","IE0002141913.USD","SGXZ23171101.USD","LU0122379950.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1989763690.USD","IE00BFTCPJ56.SGD","BK4581","SG9999002232.USD","LU2237957902.USD","LU1721429402.USD","LU2468319806.SGD","LU0234572021.USD"],"gpt_icon":0},{"id":"2533768724","title":"Moderna (MRNA) Gets a Hold from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2533768724","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533768724?lang=en_us&edition=fundamental","pubTime":"2025-05-06 19:56","pubTimestamp":1746532611,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $30.00. The company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/moderna-mrna-gets-a-hold-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/moderna-mrna-gets-a-hold-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4551","BK4568","BK4585","BK4588","BK4566","BK4501","BK4127","COWN","BK4532","MRNA","BK4534","BK4207","TD","BK4533","BK4139"],"gpt_icon":0},{"id":"2533507546","title":"BioNTech Se : Citigroup Cuts Target Price to $140 From $145","url":"https://stock-news.laohu8.com/highlight/detail?id=2533507546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533507546?lang=en_us&edition=fundamental","pubTime":"2025-05-06 18:22","pubTimestamp":1746526958,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nFWN3RE16K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BNTX","BK4535","BK4548","BK4551","BK4588","BK4585","BK4139","BK4568"],"gpt_icon":0},{"id":"2533850486","title":"BioNTech price target lowered to $140 from $145 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2533850486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533850486?lang=en_us&edition=fundamental","pubTime":"2025-05-06 17:50","pubTimestamp":1746525046,"startTime":"0","endTime":"0","summary":"Citi lowered the firm’s price target on BioNTech (BNTX) to $140 from $145 and keeps a Buy rating on the shares following the Q1 report. The quarter...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-140-from-145-at-citi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-140-from-145-at-citi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4535","BK4568","BK4588","BK4139","BNTX","BK4551","BK4585"],"gpt_icon":0},{"id":"2533545996","title":"BioNTech SE Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533545996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533545996?lang=en_us&edition=fundamental","pubTime":"2025-05-06 12:04","pubTimestamp":1746504267,"startTime":"0","endTime":"0","summary":"Biontech Se Sponsored Adr ( ($BNTX) ) has released its Q1 earnings. Here is a breakdown of the information Biontech Se Sponsored Adr presented to i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biontech-se-reports-q1-2025-financial-results-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biontech-se-reports-q1-2025-financial-results-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4588","BK4548","BK4551","BK4568","BNTX","BK4139","BK4585"],"gpt_icon":0},{"id":"2533856130","title":"Health Care Down on Mixed Earnings -- Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2533856130","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533856130?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:41","pubTimestamp":1746481260,"startTime":"0","endTime":"0","summary":"Health-care companies ticked down amid mixed fortunes for the sector.BioCryst Pharmaceuticals shares surged after the biotech firm said it would turn a profit in 2025, a year earlier than anticipated, amid robust demand for Oraldeyo, a treatment for rare disease hereditary angioedema.BioNTech, the German biotech firm that rose to fame when it partnered with Pfizer on a Covid 19 vaccine, logged a hefty first-quarter loss and said it would focus on promising oncology programs from now on, citing risks to its current franchise from public policy and opinion.Henry Schein's first-quarter net income rose and the company backed its 2025 adjusted earnings projection as increased doctor-office visits buoyed medical sales, offsetting weakness in demand for dental-supply sales and the impact of a strong dollar.Health insurer UnitedHealth Group said it now has a thousand artificial-intelligence applications in production.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1066053197.SGD","SG9999001176.SGD","LU1883839398.USD","SG9999003800.SGD","LU1066051498.USD","LU0225284248.USD","LU1894683348.USD","IE00BBT3K403.USD","LU0225771236.USD","LU0306806265.USD","IE00B19Z3581.USD","LU0985481810.HKD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0321505868.SGD","LU0122379950.USD","LU1057294990.SGD","SG9999011175.SGD","BK4550","IE00BLSP4239.USD","BK4581","SG9999002224.SGD","IE0002270589.USD","BK4534","LU0058720904.USD","SG9999001176.USD","LU0170899867.USD","IE000M9KFDE8.USD","LU0306807586.USD","BK4533","LU1894683264.USD","LU0289739699.SGD","BK4585","BK4599","LU0321505439.SGD","SG9999013999.USD","LU1023059063.AUD","BK4592","LU0234572021.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0868494617.USD","BK4568","BK4007","SG9999002232.USD"],"gpt_icon":1},{"id":"2533576563","title":"Press Release: Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2533576563","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533576563?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:30","pubTimestamp":1746477000,"startTime":"0","endTime":"0","summary":"Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors. Directors Rajiv Malik and Harry Korman to Retire at the End of Their Current Terms. PITTSBURGH, May 5, 2025 /PRNewswire/ -- Viatris Inc. , a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, Frank D'Amelio and Michael Severino, M.D., have been appointed as the newest members of Viatris' Board of Directors. In addition, the Company announced that current directors, Rajiv Malik and Harry  Korman, will retire from the Board at the end of their current terms in December following the Company's 2025 Annual Meeting of Shareholders.Severino serves on the Board of Directors of Avantor, Inc., Montai Therapeutics, Inc., and Quotient Therapeutics, Inc. He earned an M.D. from Johns Hopkins University, completing his residency and fellowship training at Massachusetts General Hospital and Harvard Medical School, as well as a bachelor's degr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","SG9999011175.SGD","BK4592","BK4599","IE0002270589.USD","LU0306806265.USD","LU1066051498.USD","LU0234572021.USD","LU0122379950.USD","IE000M9KFDE8.USD","SG9999013999.USD","LU1894683348.USD","SG9999001176.SGD","SG9999001176.USD","LU1023059063.AUD","LU1894683264.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0225284248.USD","BK4581","IE00B19Z3581.USD","LU0456855351.SGD","LU0289739699.SGD","LU1066053197.SGD","LU1839511570.USD","LU0868494617.USD","LU0985481810.HKD","LU0321505439.SGD","SG9999002224.SGD","LU0225771236.USD","LU2087621335.USD","BK4550","LU1883839398.USD","BK4533","VTRS","BK4588","LU0321505868.SGD","IE00BLSP4239.USD","LU0306807586.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","SG9999002232.USD","BK4007","BK4585","BK4568","BK4583","SG9999003800.SGD","LU0170899867.USD"],"gpt_icon":1},{"id":"2533573305","title":"BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2533573305","media":"Benzinga","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533573305?lang=en_us&edition=fundamental","pubTime":"2025-05-06 03:49","pubTimestamp":1746474564,"startTime":"0","endTime":"0","summary":"BioNTech&#39;s Q1 revenue hit $192 million, beating estimates; company confirms 2025 outlook and names new CFO ahead of oncology-focused expansion.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/05/45205736/biontech-appoints-novartis-executive-as-finance-chief-reaffirms-2025-guidance-focuses-on-oncology-expansion","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","BK4568","IE0002270589.USD","LU1057294990.SGD","LU1066053197.SGD","LU0208291251.USD","SG9999003800.SGD","IE00B2B36J28.USD","BK4578","BK4534","IE00BJT1NW94.SGD","LU0058720904.USD","BK4592","LU0225284248.USD","LU1883839398.USD","SG9999001176.SGD","LU1894683348.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","IE00BLSP4452.SGD","BK4533","BNTX","LU0225771236.USD","LU0306806265.USD","LU0321505439.SGD","LU0306807586.USD","IE00B4R5TH58.HKD","LU0456855351.SGD","BK4548","LU0170899867.USD","BK4139","BK4550","BK4551","IE000M9KFDE8.USD","IE0002141913.USD","BK4585","IE00B19Z3B42.SGD","LU0234572021.USD","SG9999002224.SGD","LU0289739699.SGD","SG9999013999.USD","LU1023059063.AUD","SG9999011175.SGD","BK4007","BK4535","LU1894683264.USD","NVS","IE00BFTCPJ56.SGD","BK4532"],"gpt_icon":1},{"id":"2533551210","title":"Optimism is Back for Biotech Stocks. This Time, It Could Last. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2533551210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533551210?lang=en_us&edition=fundamental","pubTime":"2025-05-06 02:49","pubTimestamp":1746470940,"startTime":"0","endTime":"0","summary":"Something strange has been happening with biotech stocks over the past few weeks: They have been going up.The SPDR S&P Biotech ETF, a benchmark for the sector, closed April 8 at $69.80, its worst closing price since November 2023. It was up 20% from that low by the end of the day on Friday, outperforming the S&P 500, which was up 14%. It had trounced the Health Care Select Sector SPDR ETF, which follows healthcare stocks writ large and was up 4.2%.The hope now is that the recent run-up, which began as the overall market surged after President Donald Trump delayed most of his promised tariffs by 90 days on April 9, is the first taste of a broader biotech recovery. The fear is that it is just a brief respite, driven by events outside the sector, from a selloff that will inevitably continue.Still, taking out the trash probably isn't enough to resurrect the sector. What biotech needs is to make some money, and these days that mostly means big pharma pulling out a checkbook and writing","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0985481810.HKD","LU1066051498.USD","IE0002270589.USD","BK4550","IE00BLSP4239.USD","LU0058720904.USD","LU0321505439.SGD","BK4504","LU0306807586.USD","SG9999001176.SGD","SSO","BK4559","LU0321505868.SGD","LU1066053197.SGD","SG9999013999.USD","LU0868494617.USD","ESmain","SG9999011175.SGD","SPY","BK4534","OEX","LU1894683348.USD","OEF","THRD","SDS","IVV","BK4568","PFE","OP.USD.HKCC","IE000M9KFDE8.USD","SG9999003800.SGD","LU1894683264.USD","LU0170899867.USD","BK4588","SH","BK4007","SPXU","BK4585","FDN","SG9999002232.USD",".SPX","LU0225771236.USD","BK4533","BK4599","BK4592","IE00BLSP4452.SGD","LU1057294990.SGD","VOO"],"gpt_icon":1},{"id":"2533559306","title":"BioNTech price target lowered to $127 from $143 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2533559306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533559306?lang=en_us&edition=fundamental","pubTime":"2025-05-06 02:10","pubTimestamp":1746468634,"startTime":"0","endTime":"0","summary":"BofA analyst Tazeen Ahmad lowered the firm’s price target on BioNTech (BNTX) to $127 from $143 and keeps a Buy rating on the shares. The firm notes...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-127-from-143-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-127-from-143-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4585","BK4548","BNTX","BK4551","BK4139","BK4588","BK4535"],"gpt_icon":0},{"id":"2533947556","title":"Sector Update: Health Care Stocks Lower Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2533947556","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533947556?lang=en_us&edition=fundamental","pubTime":"2025-05-06 02:03","pubTimestamp":1746468181,"startTime":"0","endTime":"0","summary":"Health care stocks fell Monday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund  decreasing 0.1%.The iShares Biotechnology ETF  shed 0.3%.In corporate news, BioNTech  shares dropped 2.7% after the company reported an unexpected decline in Q1 sales.Capricor Therapeutics  shares tumbled past 10% after the company said the US Food and Drug Administration plans to hold an advisory committee meeting to review its biologics license application for deramiocel, an investigational cell therapy for treating cardiomyopathy in Duchenne muscular dystrophy patients.Rezolute  shares popped 2.9% after the company said the FDA granted breakthrough therapy designation for ersodetug, an investigational treatment for hypoglycemia caused by tumor hyperinsulinism.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","XLV","BK4535","RZLT","BK4581","BK4551","BK4139","BK4585","BK4568","BK4548","BNTX","CAPR","IBB"],"gpt_icon":0},{"id":"2533336559","title":"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533336559","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533336559?lang=en_us&edition=fundamental","pubTime":"2025-05-06 01:50","pubTimestamp":1746467408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioNTech SE (BNTX – Research Report), PTC Therapeuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-ptc-therapeutics-ptct-and-larimar-therapeutics-lrmr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-ptc-therapeutics-ptct-and-larimar-therapeutics-lrmr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4548","LU2362541513.USD","BNTX","BK4576","LU1951198990.SGD","BK4535","PTC","HCSG","LU1923623000.USD","BK4588","LU2362540622.SGD","LU2362541273.HKD","BK4139","LU0320765992.SGD","LRMR","LU2506952337.HKD","PTCT","LU0109394709.USD","LU2506952410.USD","BK4023","BK4137","BK4554","BK4551","LU1721428347.USD","BK4585","LU2477742899.HKD","LU0889565916.HKD","LU1951200564.SGD"],"gpt_icon":0},{"id":"2533396715","title":"Narrower Guidelines for Covid-19 Booster Wouldn't Limit BioNTech's Customer Base Much -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2533396715","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533396715?lang=en_us&edition=fundamental","pubTime":"2025-05-05 23:13","pubTimestamp":1746457980,"startTime":"0","endTime":"0","summary":"1112 ET - BioNTech expects its Covid-19 booster sales to stay relatively stable even if the government narrows its recommendations of who needs the shot. The Centers for Disease Control is scheduled to vote in June on a new recommendation for who should get the Covid-19 booster, which could narrow it to high-risk groups only. BioNTech, which rose to prominence for its partnership with Pfizer during the Covid-19 pandemic, says during an analyst call that many of the people still getting the booster are in high-risk groups already. The majority of Covid vaccines in the U.S. are going to people who are older than 65 or immunocompromised, which accounts for about 20% of Americans, management says. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1883839398.USD","SG9999013999.USD","SG9999001176.USD","LU0321505868.SGD","LU0170899867.USD","LU0289739699.SGD","SG9999001176.SGD","IE00BLSP4452.SGD","BK4581","LU0122379950.USD","SGXZ57979304.SGD","LU0225284248.USD","SG9999002232.USD","BK4599","BNTX","LU1894683348.USD","LU0306806265.USD","LU0058720904.USD","BK4568","BK4588","LU0985481810.HKD","BK4007","LU0225771236.USD","SG9999003800.SGD","LU1066051498.USD","LU0306807586.USD","LU1023059063.AUD","LU0234572021.USD","IE00B19Z3581.USD","LU0456855351.SGD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU1066053197.SGD","BK4550","LU1057294990.SGD","IE000M9KFDE8.USD","LU0321505439.SGD","BK4533","BK4585","IE00BBT3K403.USD","BK4534","BK4592","LU0868494617.USD","SG9999002224.SGD","SG9999011175.SGD","IE0002270589.USD"],"gpt_icon":1},{"id":"2533539125","title":"European Equities Traded in the US as American Depositary Receipts Marginally Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2533539125","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533539125?lang=en_us&edition=fundamental","pubTime":"2025-05-05 23:12","pubTimestamp":1746457927,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were marginally higher late Monday morning, rising 0.06% to 1,423.70 on the S&P Europe Select ADR Index.From continental Europe, the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBVA","BK4007","BK4585","BK4588","ADAP","BK4568","BK4201","BP","MREO","AFG","BK4207","BNTX","NCNA","LU0320765646.SGD","BK4551","BK4535","EDAP","BK4505","BK4107","TRIB","BK4023","BK4546","LU0162691827.USD","CLLS","DBVT","BK4117","BK4548","E","BK4139","LU0072461881.USD","BCYC","GNFT","LU1829250122.USD","AKTX","MTLS","LU1162221912.USD","SLN","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":7,"totalSize":242,"code":"91000000","status":"200"}]}}